Studies&Me, a virtual contract research organisation, specialises in the decentralisation of clinical trials. With a patient and data-driven vision, the company aims to set new standards for clinical research by digitalising treatment development across all stages: protocol development, patient recruitment, study conduct, and continuous data reporting to both patients and healthcare professionals on their smartphones and dashboards.
Therapeutic Areas: Bacterial Infections and Mycoses, Cardiovascular Diseases, Chemically-induced Disorders, Congenital, Hereditary and Neonatal Diseases and Abnormalities, Digestive System Diseases, Disorders of Environmental Origin, Endocrine System Diseases, Eye Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Immune System Diseases, Male Urogenital Diseases, Mental Disorders, Musculoskeletal Diseases, Neoplasms, Nervous System Diseases, Nutritional and Metabolic Diseases, Occupational Diseases, Otorhinolaryngologic Diseases, Parasitic Diseases, Pathological Conditions, Signs and Symptoms, Respiratory Tract Diseases, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Virus Diseases and Wounds and Injuries.
Sub-therapeutic areas: Virtual trials; hybrid trials; decentralised trials; digitalizing treatment; end to end solutions. Other areas of expertise include accelerating patient recruitment; econsent; continuous data collection.